Synuclein-β (S118) Peptide 
Datasheet
COA
MSDS
SHIP
Product Name :
Synuclein-β (S118) Peptide Applications :
Blocking Background :
The synuclein family members, including α-synuclein (also designated NACP for non-β amyloid component) and β-synuclein, are predominantly expressed in the brain and are speculated to be involved in synaptic regulation and neuronal plasticity. α-synuclein is localized to neuronal cell bodies and synapses. α-synuclein was first identified as a component of Alzheimer’s disease amyloid plaques. Abnormal platelet function in Alzheimer’s disease has been demonstrated. During megakaryocytic differentiation α-synuclein was found to be upregulated, while β-synuclein is downregulated, indicating that coordinate expression of synucleins may be important during hematopoetic cell differentiation. A mutant form of α-synuclein has been found in patients with early onset Parkinson’s disease. Alternative Name :
SNCB; BETA-SYNUCLEIN Swiss-Prot :
Q16143 Product :
1 mg/ml in DI water. Purification&Purity :
Synthetic peptide Synuclein-β (S118). (Note: the amino acid sequence is proprietary). The purity is > 98%. Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
This peptide can be used with studies using BS1348 Synuclein-β (S118) pAb.
Synuclein-β (S118) Peptide Applications :
Blocking Background :
The synuclein family members, including α-synuclein (also designated NACP for non-β amyloid component) and β-synuclein, are predominantly expressed in the brain and are speculated to be involved in synaptic regulation and neuronal plasticity. α-synuclein is localized to neuronal cell bodies and synapses. α-synuclein was first identified as a component of Alzheimer’s disease amyloid plaques. Abnormal platelet function in Alzheimer’s disease has been demonstrated. During megakaryocytic differentiation α-synuclein was found to be upregulated, while β-synuclein is downregulated, indicating that coordinate expression of synucleins may be important during hematopoetic cell differentiation. A mutant form of α-synuclein has been found in patients with early onset Parkinson’s disease. Alternative Name :
SNCB; BETA-SYNUCLEIN Swiss-Prot :
Q16143 Product :
1 mg/ml in DI water. Purification&Purity :
Synthetic peptide Synuclein-β (S118). (Note: the amino acid sequence is proprietary). The purity is > 98%. Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
This peptide can be used with studies using BS1348 Synuclein-β (S118) pAb.
Blocking peptide available as BS1348PP